Skip to content

Axogen AXGN Other Income (Expense)

Other Income (Expense) at other companies

Baxter International logo
Baxter InternationalBAX
-$6M-300%
Stryker logo
StrykerSYK
$62M-3.1%
IAR
Integra LifeSciencesIART
$4.48M+3,211%
LeMaitre Vascular logo
LeMaitre VascularLMAT
-$127K-6,450%
Medtronic logo
MedtronicMDT
$137M
Enovis logo
EnovisENOV
$3.27M+335%

Other financials

Income statement

See full
Revenue$61.5M+26.6%
Gross profit$46.2M+32.2%
Operating income-$2.8M-70.5%
Net income-$19.6M-411%
EPS (diluted)-$0.38-375%

Balance sheet

See full
Cash & equivalents$84.7M+251%
Total debt$20.6M-69.8%
Total equity$244.8M+132%
Total assets$289.5M+47.6%

Cash flow

See full
Operating cash flow$1.6M+112%
CapEx$2.8M+989%
Free cash flow-$1.2M+90.9%

Valuation

See full
Market cap$2.26B+110%
Enterprise value$2.2B+91.4%
P/S9.5×+4.0×

Profitability

See full
Gross margin75%+0.8pp
Operating margin-3.8%
Net margin-13.2%-22.8pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18%-70.5pp
Debt / equity0.1×-0.6×
Current ratio7.1×+2.8×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axogen's other income (expense)?
Axogen (AXGN) reported other income (expense) of -$16.75M in Q1 2026.
How has Axogen's other income (expense) changed year-over-year?
Axogen's other income (expense) decreased by 670.9% year-over-year, from -$2.17M to -$16.75M.
What is the long-term trend for Axogen's other income (expense)?
Over 4 years (2021 to 2025), Axogen's other income (expense) has grown at a 48.0% compound annual growth rate (CAGR), from -$1.64M to -$7.85M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.